Home › Funds › Hikari Tsushin, Inc. › JNJ

Hikari Tsushin, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Hikari Tsushin, Inc. reported holding 82,191 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$21.8M, representing 1.46% of its reported portfolio and ranking #8 among its reported holdings. Hikari Tsushin, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)82.19K sh
Reported value held$21.76M
Portfolio Weight1.46%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hikari Tsushin, Inc.'s JNJ position evolved

Hikari Tsushin, Inc. first disclosed a stake in JNJ in Q3 2023 at 143,133 shares (US$22.3M). The position peaked in Q1 2026 at 117,095 shares, worth US$28.6M. Across 13 filings, Hikari Tsushin, Inc. increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 82,191 shares valued at US$21.8M — a reduction of -26,876 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 143.13K $22.29M New
Q4 2023 136.47K $21.39M Reduce
Q1 2024 136.47K $21.59M Hold
Q2 2024 136.92K $20.01M Hold
Q3 2024 136.92K $22.19M Hold
Q4 2024 136.92K $19.80M Hold
Q1 2025 136.92K $22.71M Hold
Q2 2025 136.92K $20.91M Hold
Q3 2025 136.92K $25.39M Hold
Q4 2025 129.20K $26.74M Reduce
Q1 2026 117.09K $28.62M Reduce
Q2 2026 109.07K $27.70M Reduce
Q3 2026 82.19K $21.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Hikari Tsushin, Inc. held JNJ?

Hikari Tsushin, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hikari Tsushin, Inc.'s current position in JNJ?

As of Q3 2026, Hikari Tsushin, Inc. holds 82.19K shares of JNJ (JOHNSON & JOHNSON), valued at $21.76M, representing 1.46% of its reported portfolio and ranking #8.

Has Hikari Tsushin, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Hikari Tsushin, Inc. reduced its position in JNJ. The position peaked in Q1 2026 at 117.09K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.